These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29759654)

  • 1. Letter comments on EJC published paper: 'No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study'.
    Zahl PH
    Eur J Cancer; 2018 Jul; 97():49-50. PubMed ID: 29759654
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer Study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jul; 97():51-52. PubMed ID: 29759655
    [No Abstract]   [Full Text] [Related]  

  • 3. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager M; Adami HO; Bretthauer M; Tamimi RM
    Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Screening Illustrator: separating the effects of lead-time and overdiagnosis in mammography screening.
    Lousdal ML; Møller MH; Kristiansen IS; Kalager M; Wisløff T; Støvring H
    Eur J Public Health; 2018 Dec; 28(6):1138-1142. PubMed ID: 29796623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program.
    Hofvind S; Román M; Sebuødegård S; Falk RS
    J Med Screen; 2016 Dec; 23(4):203-209. PubMed ID: 26940960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.
    Monticciolo DL; Helvie MA; Hendrick RE
    AJR Am J Roentgenol; 2018 Feb; 210(2):285-291. PubMed ID: 29091010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Overdiagnosis in mammography screening for breast cancer].
    Huang YB; Yang L; Song FJ; Chen KX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1574-1578. PubMed ID: 29141352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
    Michalopoulos D; Duffy SW
    J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do women receive enough information to make informed choices about breast cancer screening?].
    Hofmann B
    Tidsskr Nor Laegeforen; 2020 Feb; 140(3):. PubMed ID: 32105039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.
    van Luijt PA; Rozemeijer K; Naber SK; Heijnsdijk EA; van Rosmalen J; van Ballegooijen M; de Koning HJ
    J Med Screen; 2016 Dec; 23(4):210-216. PubMed ID: 27068430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?
    Rahbar H; McDonald ES; Lee JM; Partridge SC; Lee CI
    Acad Radiol; 2016 Jun; 23(6):768-73. PubMed ID: 27017136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Screening Frequency and Overdiagnosis.
    Ponti A; Frigerio A; Marra V; Armaroli P; Segnan N
    J Am Coll Radiol; 2017 Dec; 14(12):1520. PubMed ID: 29202932
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast Cancer Overdiagnosis Common Among Older Women.
    Harris E
    JAMA; 2023 Sep; 330(9):797. PubMed ID: 37585235
    [No Abstract]   [Full Text] [Related]  

  • 20. Accepting the Existence of Breast Cancer Overdiagnosis.
    Brawley OW
    Ann Intern Med; 2017 Mar; 166(5):364-365. PubMed ID: 28114628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.